Chinese Scientists Create Mutant Ebola Virus

In a concerning development, Chinese scientists have conducted a potentially risky experiment in which they engineered a pathogen using parts of the Ebola virus in a laboratory setting.

The purported aim of this endeavor was to gain a better understanding of the disease caused by the Ebola virus, but it has raised significant alarms due to its resemblance to the gain-of-function research that led to the emergence of the COVID-19 pandemic from the Wuhan Institute of Virology.

As reported by Big League Politics and the Daily Mail, researchers at Hebei Medical University were responsible for this controversial undertaking.

They combined a contagious livestock disease with a protein found in Ebola, enabling the resulting pathogen to infect cells and spread throughout the human body.

This approach bears striking similarities to the gain-of-function research conducted with bat coronaviruses in Wuhan, which ultimately resulted in COVID-19.

The engineered pathogen was then administered to hamsters, leading to their demise within two to three days.

Notably, those exposed to the lethal virus exhibited severe systemic diseases akin to those observed in human Ebola patients, including multi-organ failure.

Additionally, infected hamsters developed distressing symptoms such as eye secretions that impaired their vision and caused scabbing over their eyeballs.

While proponents of this study suggested that infected hamsters could serve as viable models for studying Ebola transmission and treatment, legitimate concerns about potential lab leaks leading to broader dissemination of the modified pathogen were raised.

It is essential to note that handling Ebola necessitates Biosafety Level 4 (BSL-4) facilities – highly secure laboratories designed for handling dangerous pathogens – whereas many labs operate at BSL-2 levels.

The escape of SARS-CoV-2 from a BSL-4 facility exemplifies how even high-security labs are not immune to containment breaches.

The reckless nature of such experiments is underscored by observations made during this study where organs harvested from deceased animals revealed viral accumulation in various tissues throughout their bodies.

These findings highlighted that even though BSL-2 security measures were utilized for this experiment due to stringent requirements for handling Ebola, there are inherent risks associated with such practices.

Ebola virus disease is described as an iconic hemorrhagic fever characterized by non-specific symptoms such as fever, malaise, headache, diarrhea or vomiting; it can rapidly progress to multiple organ failure and shock, often resulting in fatalities with case fatality rates ranging between 25 and 90 percent

. The potential for respiratory viruses like Ebola – which can be transmitted through coughing and sneezing – poses significant concerns about widespread dissemination within populations.

Moreover, data released earlier this year revealed annual occurrences of lab leak incidents involving controlled pathogens like tuberculosis and anthrax.

These revelations serve as stark reminders of how dangerous biolab experiments continue despite lessons that should have been learned from previous pandemics like COVID-19.

While scientific research plays an invaluable role in advancing our understanding of infectious diseases like Ebola, it is crucial that ethical considerations and stringent safety protocols are upheld at all times.

The implications of mishandling potentially lethal pathogens underscore the need for global vigilance when conducting high-risk experiments within laboratory settings

ICYMI: CNN Criticizes Kamala Harris for Dangerous Price Control Scheme